SAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?

investorplace2021-09-23

Companies seeking approval for drugs treating Alzheimer’s disease have tended to be among the stocks biotech investors watched but didn’t hold much hope for. That’s because prior to the Food and Drug ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Mundoo
2021-09-23
Mundoo
selling put on this....what yall think?
sugizoi4u
2021-09-23
sugizoi4u
Bullish on the future of SAVA. It’s still very cheap
Jasonngui
2021-09-23
Jasonngui
Down more pls!
- JerryChiang:
  haven't load enough?
- Basketrif:
  Why do u like abt this stk
Jasonngui
2021-09-23
Jasonngui
Great

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196282556?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-23 08:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196282556","market":"us","top_or_hot":-1,"title":"SAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?","media":"investorplace","content":"<div>\n<p>Companies seeking approval for drugs treating Alzheimer’s disease have tended to be among the stocks biotech investors watched but didn’t hold much hope for. That’s because prior to the Food and Drug ...</p>\n\n<a href=\"https://investorplace.com/2021/09/sava-stock-what-is-going-on-with-red-hot-cassava-sciences-today/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 08:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/sava-stock-what-is-going-on-with-red-hot-cassava-sciences-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Companies seeking approval for drugs treating Alzheimer’s disease have tended to be among the stocks biotech investors watched but didn’t hold much hope for. That’s because prior to the Food and Drug ...</p>\n\n<a href=\"https://investorplace.com/2021/09/sava-stock-what-is-going-on-with-red-hot-cassava-sciences-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SAVA","symbol_name":"Cassava Sciences Inc","start_time":0,"source_url":"https://investorplace.com/2021/09/sava-stock-what-is-going-on-with-red-hot-cassava-sciences-today/","article_id":"1196282556","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196282556","pubTimestamp":1632357974,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Companies seeking approval for drugs treating Alzheimer’s disease have tended to be among the stocks","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SAVA":"Cassava Sciences Inc"},"translate_title":"萨瓦·斯托克：今天红火的木薯科学是怎么回事？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SAVA":0.9},"content_text":"Companies seeking approval for drugs treating Alzheimer’s disease have tended to be among the stocks biotech investors watched but didn’t hold much hope for. That’s because prior to the Food and Drug Administration (FDA)approval of aducanumab, such treatments were seen as longshots, to say the least. However, investors in Cassava Sciences(NASDAQ:SAVA) and SAVA stock have certainly been following these developments closely.\nThat’s because Cassava is another player in the race to develop better, more effective Alzheimer’s treatments.\nGiven the scale of this disease, as well as the recent approval handed down from the FDA, there’s a lot of room for hope today among biotech investors in companies such as Cassava. Indeed, the recent run this stock has been on indicates sentiment remains broadly bullish for SAVA stock.\nHowever, today, SAVA stock has seen some rather incredible volatility. This morning, SAVA stock shot up approximately 15% higher from yesterday’s close. However, currently, this stock is trading down approximately 6% on very heavy volume.\nLet’s dive into what’s been the key cause of this volatility in Cassava Sciences today.\nSAVA Stock Jumps, Sells Off on Top-Line Results\nToday, Cassava Sciencesshared interim data on an ongoing study of the company’s Simufilam drug for those with mild to moderate Alzheimer’s disease. The results were broadly positive, leading investors to bid up shares in a hurry.\nThe company reported that cognition scores improved substantially among the first 50 subjects. Additionally, the drug was well-tolerated among patients enrolled in the study, and no serious adverse effects were reported.\nIndeed, that’s all incredibly positive.\nHowever, it appears investors have been quick to take these data with a big grain of salt. Today’s afternoon selloff appears to be the result of growing skepticism among the results Cassava, and other Alzheimer’s-focused biotech stocks, produce. That’s because of somehigh-profile opposition to the initial data that got aducanumab approved in the first place.\nIndeed, SAVA stock is likely to remain a highly volatile stock for investors from here. Those looking to invest in Cassava Sciences, or any biotech for that matter, ought to be aware of the downside risk that comes along with the potential upside investors seek.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":863888106,"gmtCreate":1632373930805,"gmtModify":1676530766827,"author":{"id":"3568936983703270","authorId":"3568936983703270","name":"Mundoo","avatar":"https://static.tigerbbs.com/14653026067d9f45dd729077618c70b6","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3568936983703270","authorIdStr":"3568936983703270"},"htmlText":"selling put on this....what yall think?","listText":"selling put on this....what yall think?","text":"selling put on this....what yall think?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863888106","repostId":1196282556,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":863136566,"gmtCreate":1632362881055,"gmtModify":1676530763514,"author":{"id":"3580348004146675","authorId":"3580348004146675","name":"sugizoi4u","avatar":"https://static.tigerbbs.com/c7f987f771f67981d200c8f1cd598c70","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3580348004146675","authorIdStr":"3580348004146675"},"htmlText":"Bullish on the future of SAVA.&nbsp;It’s still very cheap","listText":"Bullish on the future of SAVA.&nbsp;It’s still very cheap","text":"Bullish on the future of SAVA. It’s still very cheap","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863136566","repostId":1196282556,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":863314278,"gmtCreate":1632358358394,"gmtModify":1676530761162,"author":{"id":"3581937655679729","authorId":"3581937655679729","name":"Jasonngui","avatar":"https://static.tigerbbs.com/4257d49eb28e662a88192e8c09a3ffaf","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581937655679729","authorIdStr":"3581937655679729"},"htmlText":"Down more pls!","listText":"Down more pls!","text":"Down more pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/863314278","repostId":1196282556,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5966679,"gmtCreate":1632362711780,"gmtModify":1663234306252,"authorId":3576907825888639,"author":{"id":3576907825888639,"idStr":"3576907825888639","authorId":3576907825888639,"name":"JerryChiang","avatar":"https://static.tigerbbs.com/537811c4027e5f1664a45ab303892cb1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":863314278,"type":1,"supId":0,"prevId":0,"content":"haven't load enough?","text":"haven't load enough?","html":"haven't load enough?"},{"id":5965608,"gmtCreate":1632359460616,"gmtModify":1663234300946,"authorId":3574715322913604,"author":{"id":3574715322913604,"idStr":"3574715322913604","authorId":3574715322913604,"name":"Basketrif","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","vip":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":863314278,"type":1,"supId":0,"prevId":0,"content":"Why do u like abt this stk","text":"Why do u like abt this stk","html":"Why do u like abt this stk"}],"langContent":"EN"},{"id":863314364,"gmtCreate":1632358344958,"gmtModify":1676530761158,"author":{"id":"3581937655679729","authorId":"3581937655679729","name":"Jasonngui","avatar":"https://static.tigerbbs.com/4257d49eb28e662a88192e8c09a3ffaf","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581937655679729","authorIdStr":"3581937655679729"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863314364","repostId":1196282556,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":71,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196282556"}